OGN
Organon & Co.
NYSE · Healthcare · Drug Manufacturers - General · US
$13.75
−0.04%Forward multiples
Based on analyst estimates
- P/E forward
- 3.94x
- P/E 2026E
- 4.10x
- P/E 2027E
- 3.79x
- P/E 2028E
- 3.43x
- P/S forward
- 0.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.41x
- PEG TTM
- 0.05x
- Price / book
- 3.59x
- Price / sales
- 0.59x
- Price / cash flow
- 4.90x
Enterprise value
- Enterprise value
- $11.0B
- EV / sales
- 1.80x
- EV / EBITDA
- 8.40x
- EV / EBIT
- 9.33x
- Market cap
- $3.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026